Novel Tat-peptide chelates for direct transduction of technetium-99m and rhenium into human cells for imaging and radiotherapy

Bioconjugate Chemistry

Volumn 11, Issue 6, 2000, Pages 762-771

  Polyakov, V ^a   Sharma, V ^a   Dahlheimer, J L ^a   Pica, C M ^a   Luker, G D ^a   Piwnica Worms, D ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOSYNTHESIS; BODY FLUIDS; CELLS; CYTOLOGY; DIAGNOSIS; DISEASES; FLUORESCENCE MICROSCOPY; ISOMERS; MEDICAL IMAGING; METAL COMPLEXES; PEPTIDES; RADIOTHERAPY; RHENIUM COMPOUNDS; TIN; TIN COMPOUNDS;

HIV-1 TAT; HUMAN CELLS; IN-VIVO; NOVEL APPLICATIONS; PERMEANTS; PROTEIN SEQUENCES; TAT PEPTIDE; TECHNETIUM-99M; TRANSACTIVATION; TRANSCHELATION;

CHELATION;

ANIMALIA; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; MURINAE;

EID: 0033657521     PISSN: 10431802     EISSN: None     Source Type: Journal    
DOI: 10.1021/bc000008y     Document Type: Article

References (54)

1. Technetium-99mlabeled receptor-specific small-molecule radiopharmaceuticals: Recent developments and encouraging results
2. 99mTc-labeled small peptides as diagnostic radiopharmaceuticals
3. Potential technetium small molecule radipharmaceuticals
4. Radiometal-labeled agents (non-technetium) for diagnostic imaging
5. Somatostatin receptor scintigraphy with [In-111-DTPA-D-Phe] and [I123-Tyr]octreotide: The Rotterdam experience with more than 1000 patients
6. Thrombus imaging using technetium-99m-labeled high-potency GPIIb/ IIIa receptor antagonists. Chemistry and initial biological studies
7. Pre-clinical evaluation of technetium-99m platelet receptor-binding peptide
8. Metal compounds in therapy and diagnosis
9. Technetium radiopharmaceuticals fundamentals, synthesis, structure and development
10. Therapeutic radiopharmaceuticals
11. The membrane dipole potential in a total membrane potential model: Applications to hydrophobic ion interactions with membranes
12. Cell internalization of the third helix of the Antennapedia homeodomain is receptor-independent
13. Polyreactive anti-DNA monoclonal antibodies and a derived peptide as vectors for the intracyto-plasmic and intranuclear translocation of macromolecules
14. Intercellular trafficking and protein delivery by a Herpesvirus structural protein
15. Functional similarity of HIV-1 rev and HTLV-1 rex proteins: Identification of a new nucleolartargeting signal in rev protein
16. Cellular uptake of the tat protein from human immunodeficiency virus
17. Tat-mediated delivery of heterologous proteins into cells
18. Trojan peptides: The penetratin system for intracellular delivery
19. Transduction of full-length TAT fusion proteins directly into mammalian cells: TAT-p27(Kip1) induces cell migration
20. Protection against experimental nervous system autoimmune diseases by a human immunodeficeincy virus-1 Tat peptide-based polyvalent vaccine
21. A truncated HIV-1 Tat protein basic domain rapidly translocates through the plasma membrane and accumulates in the cell nucleus
22. High-efficiency intracellular magnetic labeling with novel superparamagnetic-Tat peptide conjugates
23. Functional imaging of multidrug-resistant P-glycoprotein with an organotechnetium complex
24. Isolation and genetic characterization of human KB cell lines resistant to multiple drugs
25. Mitotic and G2 checkpoint control: Regulation of 14-3-3 protein binding by phosphorylation of Cdc25C on serine-216
26. Transmembrane chloride flux in tissue-cultured chick heart cells
27. Characterization of functional assays of P-glycoprotein transport activity
28. -: Carrier free?
29. Uptake and retention of hexakis (2-methoxy isobutyl isonitrile) technetium(I) in cultured chick myocardial cells: Mitochondrial and plasma membrane potential dependence
30. Choroid plexus epithelial expression of MDR1 P-glycoprotein and multidrug resistance-associated protein contribute to the blood-cerebrospinal fluid drug-permeability barrier
31. Novel hexakis(areneisonitrile)technetium(I) complexes as radioligands targeted to the multidrug resistance P-glycoprotein
32. Novel gallium(III) complexes transported by MDR1 P-glycoprotein: Potential PET imaging agents for probing P-glycoprotein-mediated transport activity in vivo
33. 2N'S peptidic chelator: Evidence of interconversion between the syn and anti conformations
34. 3]octreotide
35. Synthesis and characterization of technetium-99m-labeled tropanes as dopamine transporter-imaging agents
36. Characterization of multidrug-resistance P-glycoprotein transport function with an organotechnetium cation
37. 2) ethylenediamine-bis[propyl(R-benzylimino)]metal(III) cations
38. Metal complexes for therapy and diagnosis of drug resistance
39. Biochemical, cellular, and pharmacological aspects of the multidrug transporter
40. Endocytosis and targeting of exogenous HIV-1 Tat protein
41. Control of RNA initiation and elongation at the HIV-1 promoter
42. Regulation of transport pathways in tumor vessels: Role of tumor type and microenvironment
43. Pharmacokinetic considerations in the development of peptide-based imaging agents
44. Can a cysteine challenge assay predict the in vivo behavior of Tc-99m-labeled antibodies?
45. Stable one-step technetium-99m labeling of His-tagged recombinant proteins with a novel Tc(I)-carbonyl complex
46. Enhancement of fluid filtration across tumor vessels: Implications for delivery of macromolecules
47. The HIV-1 Tat nuclear localization sequence confers novel nuclear import properties
48. Microautoradiographic analysis of the normal organ distribution of radioiodinated single-chain Fv and other immunoglobulin forms
49. Biodistribution of 18F- and 125I-labeled anti-Tac disulfidestabilized Fv fragments in nude mice with interleukin 2 alpha receptor-positive tumor xenografts
50. Comparison of complete versus fragmented technetium-99m-labeled anti-CEA monoclonal antibodies for immunoscintigraphy in colorectal cancer
51. Chemical design of radiolabeled antibody fragments for low renal radioactivity levels
52. The renal handling of amino acids and oligopeptides
53. 111In-DTPA labeled receptor targeted proteins
54. Molding a peptide into an RNA site by in vivo peptide evolution